These findings indicate that high HAA intake is a risk factor of prostate cancer in Japanese men, and that the genotypes of NAT2, CYP1A1, and CYP1A2 may affect the degree of cancer risk via changes in HAA-metabolizing enzymes. This evidence concerns the gene NAT2 and prostate cancer.